StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
75
This year
8
Publishing Date
2024 - 02 - 15
1
2024 - 01 - 30
1
2024 - 01 - 23
2
2023 - 12 - 28
1
2023 - 11 - 27
1
2023 - 11 - 01
1
2023 - 05 - 19
1
2023 - 05 - 02
1
2023 - 04 - 07
1
2023 - 03 - 22
1
2023 - 01 - 24
1
2023 - 01 - 05
1
2022 - 12 - 16
1
2022 - 10 - 11
1
2022 - 09 - 06
1
2022 - 07 - 25
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 06 - 21
1
2022 - 06 - 17
2
2022 - 06 - 06
1
2022 - 05 - 30
1
2022 - 05 - 11
1
2022 - 04 - 13
1
2022 - 04 - 12
1
2022 - 03 - 23
1
2022 - 03 - 16
1
2022 - 03 - 09
1
2022 - 03 - 08
3
2022 - 02 - 23
1
2022 - 02 - 22
2
2022 - 02 - 18
2
2021 - 12 - 14
1
2021 - 11 - 15
2
2021 - 10 - 29
1
2021 - 10 - 07
1
2021 - 09 - 03
1
2021 - 09 - 02
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 19
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 06 - 29
1
2021 - 06 - 16
1
2021 - 06 - 09
2
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 05 - 24
1
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 02
2
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 16
1
2021 - 03 - 08
2
2021 - 02 - 25
1
2021 - 02 - 05
1
2020 - 12 - 02
2
Sector
Health services
2
Health technology
75
Manufacturing
7
Process industries
1
Producer manufacturing
2
Tags
Abbvie
77
Active
14
Aesthetic
22
Alliances
19
America
42
Antibody
17
Application
15
Approval
37
Atopic dermatitis
10
Biomidwest
43
Biotech-beach
10
Business
12
Cancer
53
Cd20
13
Chmp
10
Clinical-trials-phase-iii
25
Collaboration
23
Conference
32
Contract
13
Deadline
11
Dermatitis
14
Disease
65
Drug
75
Duobody
13
Earnings
22
Europe
16
Events
24
Expected
18
Eye
17
Fda
42
Financial
26
Financial results
12
Genetown
11
Global
113
Growing
24
Growth
174
Health
20
Leukemia
16
Market
383
Meeting
12
Migraine
23
N/a
783
Pharma
17
Pharmaceuticals
11
Phase 3
30
Positive
30
Reach
16
Report
97
Research
81
Results
79
Rinvoq
27
Risankizumab
14
Set
15
Skyrizi
16
Therapeutics
88
Therapy
40
Treatment
117
Trial
32
Ulcerative colitis
14
Year
12
Entities
3m company
2
Abbott laboratories
5
Abbvie inc.
75
Adc therapeutics sa
1
Albemarle corporation
1
Alkermes plc
1
Amgen inc.
18
Antares pharma, inc.
1
Aquestive therapeutics, inc.
1
Arcturus therapeutics holdings inc.
1
Arrowhead pharmaceuticals, inc.
1
Astellas pharma inc
3
Astrazeneca plc
14
Bausch health companies inc.
8
Baxter international inc.
1
Becton, dickinson and company
1
Biogen inc.
3
Biomarin pharmaceutical inc.
1
Boston scientific corporation
3
Bristol-myers squibb company
11
Catalent, inc.
2
Coherus biosciences, inc.
2
Compass pathways plc
1
Cumberland pharmaceuticals inc.
1
Eli lilly and company
14
Exelixis, inc.
1
Fresenius medical care ag & co. kgaa
1
Galapagos nv
1
Galmed pharmaceuticals ltd.
1
Genmab a/s
4
Gilead sciences, inc.
4
Glaxosmithkline plc
19
Halozyme therapeutics, inc.
1
Icon plc
1
Immunogen, inc.
1
Incyte corporation
1
Insulet corporation
1
Jazz pharmaceuticals plc
1
Johnson & johnson
25
Laboratory corporation of america holdings
1
Ligand pharmaceuticals incorporated
1
Medtronic plc
1
Novartis ag
27
Plus therapeutics, inc.
1
Puma biotechnology inc
1
Rockwell medical, inc.
1
Sanofi
24
Sutro biopharma, inc.
1
Takeda pharmaceutical company limited
5
Teleflex incorporated
1
Terumo corp
2
Teva pharmaceutical industries limited
1
Teva pharmaceutical industries ltd
9
Tff pharmaceuticals, inc.
1
Therapeuticsmd, inc.
1
Thermo fisher scientific inc
3
Ucb s.a.
2
Viatris inc.
2
West pharmaceutical services, inc.
2
Zymeworks inc.
1
Symbols
ABBV
75
ABT
64
ALGS
17
ALNY
11
ALPMF
26
ALPMY
26
AMGN
54
ARDX
11
ARQT
11
ARVL
11
AZN
69
AZNCF
47
BAX
15
BDX
34
BHC
22
BIIB
28
BIO
12
BMY
63
BSX
13
CERT
11
CRL
13
DHR
14
ENDP
13
ENVB
12
EVOTF
20
FNCTF
27
GILD
25
GLAXF
76
GLPG
12
GSK
109
HOTH
12
IMAB
11
INBS
19
INCY
33
IONS
14
JAGX
33
JNJ
224
LEXX
11
LH
14
LLY
105
LTRN
33
MDT
24
MNKD
12
NNVC
21
NVO
18
NVS
115
NVSEF
85
PFE
54
PRGO
13
SNY
240
SNYNF
173
SRNE
11
STRO
12
TAK
29
TEVJF
44
TMO
48
TNXP
12
VTRS
15
WST
14
ZLAB
11
Exchanges
Nasdaq
50
Nyse
75
Crawled Date
2024 - 02 - 15
1
2024 - 01 - 30
1
2024 - 01 - 23
2
2023 - 12 - 28
1
2023 - 11 - 27
1
2023 - 11 - 01
1
2023 - 05 - 19
1
2023 - 05 - 02
1
2023 - 04 - 07
1
2023 - 03 - 22
1
2023 - 01 - 24
1
2023 - 01 - 05
1
2022 - 12 - 16
1
2022 - 10 - 11
1
2022 - 09 - 06
1
2022 - 07 - 25
1
2022 - 06 - 24
1
2022 - 06 - 22
1
2022 - 06 - 21
1
2022 - 06 - 17
2
2022 - 06 - 06
1
2022 - 05 - 30
1
2022 - 05 - 11
1
2022 - 04 - 13
1
2022 - 04 - 12
1
2022 - 03 - 23
1
2022 - 03 - 16
1
2022 - 03 - 09
1
2022 - 03 - 08
3
2022 - 02 - 23
1
2022 - 02 - 22
2
2022 - 02 - 18
2
2021 - 12 - 14
1
2021 - 11 - 15
2
2021 - 10 - 29
1
2021 - 10 - 07
1
2021 - 09 - 03
1
2021 - 09 - 02
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 19
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 06 - 29
1
2021 - 06 - 16
1
2021 - 06 - 09
2
2021 - 06 - 04
1
2021 - 06 - 01
1
2021 - 05 - 28
1
2021 - 05 - 24
1
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 04 - 02
2
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 16
1
2021 - 03 - 08
2
2021 - 02 - 25
1
2021 - 02 - 05
1
2020 - 12 - 02
2
Crawled Time
01:00
3
03:00
3
04:00
1
06:00
1
08:00
2
09:00
2
10:10
1
11:00
3
12:00
5
13:00
4
13:30
3
14:00
3
14:07
1
14:15
1
14:30
1
15:00
4
15:11
1
15:15
1
15:20
1
15:30
3
16:00
4
17:00
4
18:00
6
19:00
4
20:00
6
21:00
1
22:00
3
23:00
3
Source
www.biospace.com
12
www.globenewswire.com
5
www.prnewswire.com
58
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Drug
symbols :
Abbv
save search
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published:
2024-03-22
(Crawled : 19:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
elahere
drug
approval
food
cancer
grants
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-4.76%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-6.97%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.51%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-1.09%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-10.41%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Global Therapeutic Antibody Market Research Report 2024: Monoclonal, Bispecific, Drug Conjugates, Others Insights and Forecasts 2019-2029
Published:
2024-02-28
(Crawled : 03:00)
- prnewswire.com
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.72%
|
O:
0.67%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
-2.39%
|
O:
-0.36%
H:
0.1%
C:
-0.6%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-9.08%
|
O:
0.6%
H:
0.02%
C:
-1.03%
drug
report
antibody
research
global
market
U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)
Published:
2024-02-27
(Crawled : 13:30)
- biospace.com/
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-8.96%
|
O:
0.13%
H:
0.0%
C:
0.0%
epkinly
drug
review
food
grants
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published:
2024-02-15
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.81
-17.59%
1.5K
|
Health Technology
|
-54.39%
|
O:
0.79%
H:
0.0%
C:
-3.21%
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.21%
|
O:
1.66%
H:
0.0%
C:
-1.59%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-5.89%
|
O:
1.66%
H:
0.0%
C:
-1.04%
TRUMY
|
$16.99
0.79%
50K
|
Manufacturing
|
-54.33%
|
O:
0.27%
H:
0.0%
C:
-2.6%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-6.84%
|
O:
0.37%
H:
0.57%
C:
0.19%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-8.53%
|
O:
-0.83%
H:
0.0%
C:
0.0%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-7.96%
|
O:
0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.38%
|
O:
-0.6%
H:
0.0%
C:
0.0%
drug
patent
report
review
global
advanced
market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.09%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
-5.84%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-13.86%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
2.2%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-1.44%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.75%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$5.18
1.57%
1.54%
250K
|
Health Technology
|
7.03%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
1.58%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-15.26%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
Published:
2024-01-23
(Crawled : 23:00)
- prnewswire.com
TRUMF
|
$16.81
-17.59%
1.5K
|
Health Technology
|
-52.31%
|
O:
-4.99%
H:
0.0%
C:
-0.06%
TRUMY
|
$16.99
0.79%
50K
|
Manufacturing
|
-50.87%
|
O:
-1.36%
H:
0.0%
C:
-0.82%
WST
|
$377.36
-0.56%
0.0%
360K
|
Health Technology
|
7.92%
|
O:
0.67%
H:
0.46%
C:
-1.49%
TFX
|
$208.3
-0.86%
0.0%
170K
|
Health Technology
|
-15.25%
|
O:
0.18%
H:
0.52%
C:
-2.57%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.81%
|
O:
-0.32%
H:
0.0%
C:
0.0%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
18.59%
|
O:
0.61%
H:
1.52%
C:
0.03%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-3.71%
|
O:
0.16%
H:
0.84%
C:
0.08%
BSX
|
$67.96
-0.24%
1.53%
6.2M
|
Health Technology
|
12.37%
|
O:
-0.18%
H:
0.5%
C:
-0.98%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-1.34%
|
O:
1.44%
H:
0.0%
C:
0.0%
PODD
|
$166.245
-3.74%
-3.89%
680K
|
Health Technology
|
-15.46%
|
O:
0.07%
H:
1.08%
C:
-1.59%
drug
global
growth
market
Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio
Published:
2024-01-23
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
0.5%
|
O:
-2.34%
H:
0.43%
C:
0.43%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-0.72%
|
O:
-2.16%
H:
1.17%
C:
1.17%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-13.7%
|
O:
0.46%
H:
0.0%
C:
0.0%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
-4.47%
|
O:
0.17%
H:
1.33%
C:
0.94%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-14.43%
|
O:
-0.96%
H:
0.3%
C:
0.28%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
1.06%
|
O:
-0.76%
H:
0.38%
C:
0.13%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-0.98%
|
O:
0.37%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-4.98%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.29%
|
O:
-2.05%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
1.68%
|
O:
-1.27%
H:
0.8%
C:
0.69%
drug
hospital
infection
therapeutics
growth
market
Biological Drug API Manufacturing Services Market Report 2023-2033 - Single Use Technology will Become Essential Over the Next Decade
Published:
2023-12-28
(Crawled : 18:00)
- prnewswire.com
TMO
|
News
|
$547.25
-1.32%
-0.02%
1.6M
|
Health Technology
|
4.45%
|
O:
0.12%
H:
0.0%
C:
0.0%
CTLT
|
$55.96
0.32%
0.0%
1.9M
|
Health Technology
|
22.59%
|
O:
-0.26%
H:
1.19%
C:
0.35%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
5.48%
|
O:
0.75%
H:
0.24%
C:
-0.32%
drug
services
report
technology
market
AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the Treatment of Relapsed/Refractory Follicular Lymphoma
Published:
2023-11-27
(Crawled : 12:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
16.83%
|
O:
-0.26%
H:
0.0%
C:
0.0%
epkinly
drug
abbvie
food
treatment
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published:
2023-11-01
(Crawled : 18:00)
- prnewswire.com
ALPMY
|
News
|
$9.34
-1.11%
690K
|
Manufacturing
|
-23.18%
|
O:
-1.46%
H:
3.67%
C:
3.26%
ZYME
|
$8.86
-0.78%
-0.79%
370K
|
Health Technology
|
27.21%
|
O:
1.14%
H:
0.42%
C:
-0.7%
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-3.08%
|
O:
1.03%
H:
0.73%
C:
0.58%
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
561.6%
|
O:
-0.16%
H:
6.42%
C:
4.49%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
14.09%
|
O:
-0.86%
H:
0.0%
C:
0.0%
STRO
M
|
$3.78
-4.06%
-4.23%
720K
|
Health Technology
|
52.71%
|
O:
0.39%
H:
3.86%
C:
3.86%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-16.06%
|
O:
-0.47%
H:
1.88%
C:
1.78%
EXEL
|
$22.875
0.24%
0.24%
2.8M
|
Health Technology
|
7.33%
|
O:
-2.62%
H:
1.17%
C:
-1.66%
drug
antibody
breast
cancer
treatment
global
market
EPKINLY™ (epcoritamab-bysp) Approved by U.S. Food and Drug Administration as the First and Only Bispecific Antibody to Treat Adults with Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Published:
2023-05-19
(Crawled : 16:00)
- globenewswire.com
GNMSF
|
$285.11
3.83%
420
|
Health Technology
|
-30.43%
|
O:
0.61%
H:
1.26%
C:
1.24%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
13.32%
|
O:
0.29%
H:
1.35%
C:
0.87%
GMAB
|
$28.51
-3.13%
-3.23%
360K
|
Health Technology
|
-27.65%
|
O:
0.54%
H:
2.0%
C:
1.81%
drug
antibody
approved
food
Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
Published:
2023-05-02
(Crawled : 11:00)
- globenewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
5.74%
|
O:
-0.1%
H:
0.96%
C:
-1.26%
PSTV
|
$1.74
-0.57%
-0.57%
28K
|
Health Technology
|
-56.14%
|
O:
2.01%
H:
0.0%
C:
-9.09%
pharma
drug
ongoing
trials
solutions
collaboration
therapeutics
plus
Ulcerative Colitis Drug Global Market Report 2022: Increasing Prevalence of Ulcerative Colitis and Inflammatory Bowel Diseases Bolsters Sector
Published:
2023-04-07
(Crawled : 11:00)
- prnewswire.com
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.66
-0.92%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
Email alert
Add to watchlist
drug
report
global
market
AbbVie Provides Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa) New Drug Application
Published:
2023-03-22
(Crawled : 13:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
3.68%
|
O:
-0.7%
H:
0.77%
C:
-1.29%
abbv-951
drug
abbvie
update
application
China Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.
Published:
2023-01-24
(Crawled : 12:00)
- prnewswire.com
UCBJY
|
$63.31
-4.38%
9.4K
|
Manufacturing
|
50.7%
|
O:
-1.31%
H:
0.39%
C:
0.17%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
118.21%
|
O:
12.34%
H:
0.0%
C:
-9.9%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
9.42%
|
O:
-0.32%
H:
0.53%
C:
-0.26%
drug
abbvie
report
china
Insights on the Allergic Conjunctivitis Global Market to 2031 - by Drug Class, Disease Type, Distribution Channel and Region
Published:
2023-01-05
(Crawled : 20:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
22.58%
|
O:
0.04%
H:
0.0%
C:
-1.84%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
2.22%
|
O:
0.35%
H:
1.43%
C:
1.28%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-19.21%
|
O:
0.74%
H:
0.44%
C:
0.07%
BHC
|
$8.66
-0.92%
0.0%
2.2M
|
Health Technology
|
22.07%
|
O:
0.84%
H:
4.71%
C:
3.46%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-0.58%
|
O:
0.83%
H:
1.98%
C:
1.04%
drug
global
disease
distribution
market
AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
Published:
2022-12-16
(Crawled : 13:00)
- prnewswire.com
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-0.34%
|
O:
-0.64%
H:
0.78%
C:
-0.97%
linzess
fda
drug
children
application
Pharmaceutical Drug Delivery Global Market Report 2022: Adoption of Nano-Based Drug Delivery Systems Presents Opportunities
Published:
2022-10-11
(Crawled : 20:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
32.29%
|
O:
-1.93%
H:
0.0%
C:
-0.17%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
23.95%
|
O:
-0.15%
H:
0.61%
C:
0.09%
NVS
|
News
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
22.36%
|
O:
-0.07%
H:
0.48%
C:
-0.66%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-10.02%
|
O:
1.29%
H:
0.0%
C:
0.0%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
31.28%
|
O:
0.0%
H:
0.67%
C:
-0.2%
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
127.94%
|
O:
-0.07%
H:
1.92%
C:
-0.86%
BSX
|
$67.96
-0.24%
1.53%
6.2M
|
Health Technology
|
72.19%
|
O:
0.38%
H:
0.35%
C:
-0.28%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
14.86%
|
O:
0.09%
H:
1.0%
C:
-1.17%
MMM
|
$90.96
-0.1%
0.0%
3.4M
|
Producer Manufacturing
|
-16.35%
|
O:
-0.25%
H:
1.04%
C:
0.35%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
16.81%
|
O:
0.76%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
23.44%
|
O:
-0.67%
H:
0.95%
C:
0.25%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
8.62%
|
O:
-0.44%
H:
1.79%
C:
0.85%
drug
global
report
market
Disease-Modifying Antirheumatic Drug (DMARD) Market to Surpass US$ 27,167.8 Million by 2030 - Coherent Market Insights
Published:
2022-09-06
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$92.116
-2.18%
2.3K
|
Health Technology
|
16.38%
|
O:
-3.02%
H:
0.0%
C:
0.0%
UCBJY
|
$63.31
-4.38%
9.4K
|
Manufacturing
|
84.31%
|
O:
0.73%
H:
2.28%
C:
1.72%
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-11.91%
|
O:
-0.65%
H:
0.93%
C:
0.71%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-29.7%
|
O:
0.03%
H:
1.18%
C:
0.13%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
18.13%
|
O:
-0.03%
H:
1.08%
C:
0.84%
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
15.15%
|
O:
0.49%
H:
0.0%
C:
0.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
6.18%
|
O:
0.44%
H:
2.03%
C:
1.76%
CPIX
|
$1.66
6.41%
6.02%
7.4K
|
Health Technology
|
-29.41%
|
O:
-4.52%
H:
7.12%
C:
5.69%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
10.06%
|
O:
0.24%
H:
1.04%
C:
0.82%
drug
market
← Previous
1
2
3
4
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.